JEANNETTE HANNA: Open Payments
NPI 1578652798 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,445 in 195 payments from 20 companies in 2025. Trend: 2023 $4,446 · 2024 $4,692 · 2025 $4,445
Food & beverage: $4,445
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $654 |
| ABBVIE INC. | 31 | $573 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $565 |
| Teva Pharmaceuticals USA, Inc. | 24 | $466 |
| Vanda Pharmaceuticals Inc. | 18 | $414 |
| Neurocrine BioSciences, Inc. | 11 | $345 |
| Otsuka America Pharmaceutical, Inc. | 10 | $233 |
| Lundbeck LLC | 9 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $153 |
| Alkermes, Inc. | 6 | $152 |
Products named: VRAYLAR, CAPLYTA, SPRAVATO, FANAPT, INGREZZA, UZEDY, REXULTI, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
